Recombinant Human CD277/BTN3A1 Fc Chimera Protein, CF
| Name | Recombinant Human CD277/BTN3A1 Fc Chimera Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 8539-BT |
| Category | Protein |
| Prices | $329.00 |
| Sizes | 50 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Human embryonic kidney cell, HEK293-derived Human CD277/BTN3A1 (Phe31-Gly254) Accession # O00481 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
| Purity | >90%, by SDS-PAGE with silver staining. |
| Bioactivity | Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED 50 for this effect is typically 1-5 µg/mL. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | O00481 |
| Gene | BTN3A1 |
| Sequence | Phe31 |
| Supplier Page | Shop |
Product images
Recombinant Human CD277/BTN3A inhibits anti-CD3 antibody-induced IL-2 secretion in human T lymphocytes. The ED 50 for this effect is typically 1-5 µg/mL.
1 μg/lane of RecombinantHuman CD277/BTN3A1 (Catalog # 8539-BT) was resolved with SDS-PAGE underreducing (R) and non-reducing (NR) conditions and visualized by silverstaining, showing bands at 58.8 and 150 kDa, respectively.